ISRCTN00283877
Completed
N/A
A multicentre study to determine the efficacy and patient acceptability of scalp cooling in the prevention of docetaxel-induced hair loss
eiden University Medical Centre (LUMC) (The Netherlands)0 sites260 target enrollmentSeptember 12, 2005
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eiden University Medical Centre (LUMC) (The Netherlands)
- Enrollment
- 260
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Intravenous administered docetaxel regimes
- •2\. Age 18 years or more
- •3\. Written informed consent
Exclusion Criteria
- •1\. Boldness before the start of the study
- •2\. Haematological malignancies with generalised haematogenic metastases (e.g. lymphoma, leukaemia and multiple myeloma) and if in those conditions chemotherapy is given with a curative intent
- •3\. Clinical signs of scalp metastases
- •4\. Cold sensitivity
- •5\. Cold agglutinin disease
- •6\. Cryoglobulinaemia
- •7\. Cryofibrinogenaemia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Multi-center study to evaluate the efficacy and to standardize RFA for early breast cancerEarly breast cancerJPRN-UMIN000008675ational Cancer Center Hospital372
Completed
N/A
Investigating the effect and safety of the Satisphere™ insert in overweight patientsISRCTN81340421Endosphere Inc (USA)60
Not Yet Recruiting
N/A
Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive ImpairmentMental and behavioural disordersKCT0007184Inha University Hospital100
Not Yet Recruiting
N/A
A multicenter clinical study to test the efficacy and safety of C1-inhibitor concentrate for clinical amniotic fluid embolism.clinical amnitotic fluid embolismJPRN-UMIN000012273Department of Obstetrics and Gynecology, Mie university hospital.5
Recruiting
N/A
Multicenter comparative study to examine the efficacy of zoledronic acid in prostate cancer with bone metastasis at different hormone sensitivity status.JPRN-UMIN000002792Tama Prostate cancer Bone metastasis Study group200